Palbociclib plus fulvestrant as first-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study
Title:
Palbociclib plus fulvestrant as first-line therapy for patients with locally advanced, inoperable or metastatic HR+/HER2- breast cancer in Germany: Interim results of the INGE-B phase II study
Author:
Welt, A. Welslau, M.K. Lüftner, D. Deryal, M. Liersch, R. Sahlmann, J. Houet, L. Vannier, C. Marschner, N. Potthoff, K.